Hence, these results indicated that the κB2 site, located at +270 upstream of the transcription start site, was responsible for the decreased expression of Nrf2 by Wogonin in resistant CML cells. The gene discussed is NFE2L2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.